Structured intelligence coverage

Structured records are temporarily unavailable. The published profile and its source ledger remain accessible.

Identity checks do not refresh the age of governance evidence. Open a record for its source date and review state.

Profile

Identity, professional record and current appointments.

Overview

Professional record at a glance

A concise summary of information supported by the cited public sources. Missing information is treated as unknown, not as a negative finding.

Current roles
21 current organization shown on this profile
Board positions
11 supported by public sources, 0 supplied by the profile owner
Committee roles
Not establishedNo committee role is currently confirmed by the cited sources
Qualifications
Not establishedNo qualification is currently confirmed by the cited sources

Professional narrative

About

Michael Farrell is Chairman of the Board and Chief Executive Officer of ResMed Inc., with 25+ years of experience at ResMed and 29+ years in healthcare and technology industries. He has held leadership roles in business development, marketing, product development, and led the global sleep apnea business. He brings deep understanding of products, operations, technology, sales and marketing.

Sources are shown with the information they support.

Current roles

Appointments & responsibilities

Executive appointments

Chairman and Chief Executive Officer

ResMed| (OTC: RSMDF)

Current

Source effective: 2025-10-02 · Observed: 2026-09-14T16:58:47.75027+00:00

confirmedView source

Board appointments

Governance

Board appointments, committee responsibilities and disclosed relationships.

Committee appointments across companies · Temporarily unavailable

Structured records for this section are unavailable. This does not establish that no records exist. Published profile sources remain in Evidence & History.

Board and advisory record

Board service

Sources are shown with each role, education record, or credential.

Chair

ResMed|

Current · start date not disclosed

Confirmed by public sourceView source

Connections

Explore the roles, education and affiliations published in this record.

ResMed|

Open ResMed| profile →

Chairman and Chief Executive Officer at ResMed|

Start not stated → End not stated

current · source reported

Observed: 2026-09-25

Chair at ResMed|

Start not stated → End not stated

current · source reported

Observed: 2026-09-25

ResMed|ResMed|Michael Farrell

Dashed lines mark past roles. Select a connection to see its dates and sources.

Relationship map

Connected through the public record

Direct relationships from verified facts and published résumé records. Private connections are excluded.

  • ResMed|

    Chairman and Chief Executive Officer

    Verified public fact

Direct public links only

Only published affiliations are shown here. Private relationships require authorized access.

Experience

Career history, education, credentials and public contributions.

Published record

Featured coverage

Selected publications and public sources used to establish this profile. Inclusion records provenance; it is not an endorsement.

Source 1 · Sec FilingRMD DEF 14A director slateSupports AI and ML experience, Board role, Committee assignments, Executive company, Executive title, Cybersecurity experience, Technology background.Open source

Basis

Identifiers, sources, dates and record limitations.

Identifiers

Alpha ID
alpha:person:michael-farrell
Record version
public-0

Published evidence records

5 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. RMD DEF 14A director slate

    sec filing · Source published: Oct 2, 2025 · Retrieved: May 15, 2026

    Supports 7 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 15, 2026
    • Board role: Board role: Chair · Claim reviewed: May 15, 2026
    • Committee assignments: No committee assignment disclosed in the cited filing · Claim reviewed: May 15, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 15, 2026
    • Executive company: Executive at ResMed Inc. · Claim reviewed: May 15, 2026
    • Executive title: Executive title: Chairman of the Board and Chief Executive Officer · Claim reviewed: May 15, 2026
    • Technology background: Technology background reported in filings · Claim reviewed: May 15, 2026

  2. ResMed Inc. director board source

    sec filing · Source published: Oct 2, 2025 · Retrieved: May 3, 2026

    Supports 2 claims
    • Board independence: Not independent (executive director) · Claim reviewed: May 3, 2026
    • Board membership: Serves on the board of ResMed Inc. · Claim reviewed: May 3, 2026

  3. Open source

    sec def 14a · Source published: Oct 2, 2025 · Retrieved: Sep 14, 2026

    Supports 2 claims
    • Professional Role: Chairman and Chief Executive Officer at ResMed| · Claim reviewed: Sep 14, 2026
    • Executive title: Executive title: Chairman and Chief Executive Officer · Claim reviewed: Sep 14, 2026

  4. Open source

    sec filing · Source published: Oct 2, 2025 · Retrieved: May 3, 2026

    Supports 1 claim
    • Professional Role: Chair at ResMed| · Claim reviewed: Sep 14, 2026

  5. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of ResMed Inc. · Claim reviewed: May 3, 2026

Sources

Sources and published information

Each item links to the public source used to support it. When sources disagree, the item is clearly marked for review.

AI and ML experience · Source reportedAI and ML experience: not identified in the cited filing1 source
Verification
Source reported
Confidence
72%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

Board independence · Source reportedNot independent (executive director)1 source
Verification
Source reported
Confidence
95%
Last reviewed
May 3, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

Board membership · CorroboratedServes on the board of ResMed Inc.Supported by 2 public records2 sources
Verification
Corroborated
Confidence
95%
Last reviewed
May 3, 2026
Board role · Source reportedBoard role: Chair1 source
Verification
Source reported
Confidence
92%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

Committee assignments · Source reportedNo committee assignment disclosed in the cited filing1 source
Verification
Source reported
Confidence
88%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

Cybersecurity experience · Source reportedCybersecurity experience: not identified in the cited filing1 source
Verification
Source reported
Confidence
72%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

Executive company · Source reportedExecutive at ResMed Inc.1 source
Verification
Source reported
Confidence
85%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

Executive title · Source reportedExecutive title: Chairman and Chief Executive Officer1 source
Verification
Source reported
Confidence
95%
Last reviewed
Sep 14, 2026
Executive title · Source reportedExecutive title: Chairman of the Board and Chief Executive Officer1 source
Verification
Source reported
Confidence
85%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

Technology background · Source reportedTechnology background reported in filings1 source
Verification
Source reported
Confidence
72%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

View all sources5 records
  1. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

    Supports: AI and ML experience · Board role · Committee assignments · Executive company · Executive title · Cybersecurity experience · Technology background

  2. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

    Supports: Board membership · Board independence

  3. https://www.sec.gov/Archives/edgar/data/943819/000094381925000079/rmd-20251001.htm

    Sec Def 14a · Tier not stated · Reviewed Sep 14, 2026

    Supports: Chairman and Chief Executive Officer at ResMed| (OTC: RSMDF) · Executive title

  4. https://www.sec.gov/Archives/edgar/data/943819/000094381925000079/rmd-20251001.htm

    Sec Filing · Tier not stated · Reviewed May 3, 2026

    Supports: Chair at ResMed| (OTC: RSMDF)

  5. https://www.sec.gov/Archives/edgar/data/943819/000094381925000079/rmd-20251001.htm

    Public Source · Tier not stated · Reviewed Not stated

    Supports: Board membership